Nav: Home

Broccoli in focus when new substance against diabetes has been identified

June 16, 2017

Researchers have identified an antioxidant - richly occurring in broccoli - as a new antidiabetic substance. A patient study shows significantly lower blood sugar levels in participants who ate broccoli extract with high levels of sulforaphane.

"There are strong indications that this can become a valuable supplement to existing medication," says Anders Rosengren, Docent in Metabolic Physiology at the University of Gothenburg.

The publication in the journal Science Translational Medicine builds on several years' research at Sahlgrenska Academy and Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, and the Faculty of Medicine at Lund University.

The objective was to find new medications against type-2 diabetes by addressing an important disease mechanism: The liver's elevated glucose production. The classic drug metformin works by doing just that, but often causes gastric side-effects and can also not be taken when kidney function is severely reduced, which affects many with diabetes.

Lowering blood sugar

The researchers began by mapping the genetic changes in the liver in diabetes. 50 genes proved to play key roles. These were then matched against different substances in the search for compounds that could affect these particular key genes, and thereby attack the disease on a broad front.

Of 2,800 substances investigated through computer-based mathematical analyses, sulforaphane proved to have the best characteristics for the task. An antioxidant that was previously studied for the treatment of cancer and inflammatory disease, but not for diabetes was thereby identified.

Cell experiments were followed by animal studies on rats and mice with dietary-induced diabetes. The blood sugar of the animals that received sulforaphane dropped by 23 percent in four weeks, and by 24 percent in those given metformin.

"We tested removing sulforaphane from the extract and the effect disappeared. We also looked at the genes from the liver of the animals and saw that the 50 key genes had been changed in the right direction," says Anders Rosengren.

Mice and men

With the knowledge that sulforaphane does not hurt people, which was already documented, a patient study was then done with around hundred patients. Basically all were on metformin treatment, but in the group that took sulforaphane every morning for 12 weeks, the patients with poor glucose control and BMI at 30 or above (well-known factors associated with elevated glucose production) had significantly lower blood sugar levels than the placebo group. In other words, sulforaphane benefited exactly those patients, totally 17 in the study, who have elevated glucose production in the liver.

A daily dose of sulforaphane is extracted from four to five kilograms of broccoli. The plan is to have a functional food preparation out within two years. Development is taking place with farmer owned organization Lantmännen.

"Sulforaphane targets a central mechanism in type 2 diabetes and has a mild side-effect profile. As functional food, it can reach the patients faster than a medication, and it is also an interesting concept from a diabetes perspective where diet is central," says Anders Rosengren.
-end-
Link to the study: http://stm.sciencemag.org/content/9/394/eaah4477

Further reading in Swedish: https://www.priushealth.org/sv/broccoli

Contact persons:

Anders Rosengren +46 (0)705 316 704; anders.rosengren@gu.se, Docent at the Institute of Neuroscience and Physiology, Sahlgrenska Academy, and the Wallenberg Centre for Molecular and Translational Medicine at the University of Gothenburg. Portrait photo: Johan Wingborg/University of Gothenburg.

Annika Axelsson +46 (0)703 591742; annika.axelsson@med.lu.se, Doctoral student at the Faculty of Medicine, Lund University. Portrait photo: Lund University

Press contact: Presskontakt: Anna von Porat +46 (0)766 186 146; anna.von.porat@gu.se

University of Gothenburg

Related Diabetes Articles:

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).
Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.
People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.
Diabetes, but not diabetes drug, linked to poor pregnancy outcomes
New research indicates that pregnant women with pre-gestational diabetes who take metformin are at a higher risk for adverse pregnancy outcomes -- such as major birth defects and pregnancy loss -- than the general population, but their increased risk is not due to metformin but diabetes.
New oral diabetes drug shows promise in phase 3 trial for patients with type 1 diabetes
A University of Colorado Anschutz Medical Campus study finds sotagliflozin helps control glucose and reduces the need for insulin in patients with type 1 diabetes.
Can continuous glucose monitoring improve diabetes control in patients with type 1 diabetes who inject insulin
Two studies in the Jan. 24/31 issue of JAMA find that use of a sensor implanted under the skin that continuously monitors glucose levels resulted in improved levels in patients with type 1 diabetes who inject insulin multiple times a day, compared to conventional treatment.
Complications of type 2 diabetes affect quality of life, care can lead to diabetes burnout
T2D Lifestyle, a national survey by Health Union of more than 400 individuals experiencing type 2 diabetes (T2D), reveals that patients not only struggle with commonly understood complications, but also numerous lesser known ones that people do not associate with diabetes.
A better way to predict diabetes
An international team of researchers has discovered a simple, accurate new way to predict which women with gestational diabetes will develop type 2 diabetes after delivery.
The Lancet Diabetes & Endocrinology: Older Americans with diabetes living longer without disability, US study shows
Older Americans with diabetes born in the 1940s are living longer and with less disability performing day to day tasks than those born 10 years earlier, according to new research published in The Lancet Diabetes & Endocrinology journal.
Reverse your diabetes -- and you can stay diabetes-free long-term
A new study from Newcastle University, UK, has shown that people who reverse their diabetes and then keep their weight down remain free of diabetes.
More Diabetes News and Diabetes Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#538 Nobels and Astrophysics
This week we start with this year's physics Nobel Prize awarded to Jim Peebles, Michel Mayor, and Didier Queloz and finish with a discussion of the Nobel Prizes as a way to award and highlight important science. Are they still relevant? When science breakthroughs are built on the backs of hundreds -- and sometimes thousands -- of people's hard work, how do you pick just three to highlight? Join host Rachelle Saunders and astrophysicist, author, and science communicator Ethan Siegel for their chat about astrophysics and Nobel Prizes.